195 related articles for article (PubMed ID: 36330895)
21. Identification of a thirteen-gene signature predicting overall survival for hepatocellular carcinoma.
Zhou X; Liu C; Zeng H; Wu D; Liu L
Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33835133
[TBL] [Abstract][Full Text] [Related]
22. Identification of immune infiltration-related genes as prognostic indicators for hepatocellular carcinoma.
Dai K; Liu C; Guan G; Cai J; Wu L
BMC Cancer; 2022 May; 22(1):496. PubMed ID: 35513781
[TBL] [Abstract][Full Text] [Related]
23. An immune subtype-related prognostic signature of hepatocellular carcinoma based on single-cell sequencing analysis.
Xie J; Chen L; Sun Q; Li H; Wei W; Wu D; Hu Y; Zhu Z; Shi J; Wang M
Aging (Albany NY); 2022 Apr; 14(7):3276-3292. PubMed ID: 35413690
[TBL] [Abstract][Full Text] [Related]
24. Identification of prognostic markers for hepatocellular carcinoma based on the epithelial-mesenchymal transition-related gene BIRC5.
Xu R; Lin L; Zhang B; Wang J; Zhao F; Liu X; Li Y; Li Y
BMC Cancer; 2021 Jun; 21(1):687. PubMed ID: 34112092
[TBL] [Abstract][Full Text] [Related]
25. Four-gene signature predicting overall survival and immune infiltration in hepatocellular carcinoma by bioinformatics analysis with RT‒qPCR validation.
Guan R; Zou J; Mei J; Deng M; Guo R
BMC Cancer; 2022 Jul; 22(1):830. PubMed ID: 35907846
[TBL] [Abstract][Full Text] [Related]
26. Development and Validation of a Novel Circadian Rhythm-Related Signature to Predict the Prognosis of the Patients with Hepatocellular Carcinoma.
Wu Y; Shen C; Wang X; Zhao W; Li Y; He X; Chen Y; Liu J; Wu X; Shen A
Biomed Res Int; 2022; 2022():4263261. PubMed ID: 35993051
[TBL] [Abstract][Full Text] [Related]
27. Mining prognostic markers of Asian hepatocellular carcinoma patients based on the apoptosis-related genes.
Yan J; Cao J; Chen Z
BMC Cancer; 2021 Feb; 21(1):175. PubMed ID: 33602168
[TBL] [Abstract][Full Text] [Related]
28. Exploring novel independent prognostic biomarkers for hepatocellular carcinoma based on TCGA and GEO databases.
Hou M
Medicine (Baltimore); 2022 Oct; 101(43):e31376. PubMed ID: 36316888
[TBL] [Abstract][Full Text] [Related]
29. Pyroptosis related genes signature predicts prognosis and immune infiltration of tumor microenvironment in hepatocellular carcinoma.
Fang G; Zhang Q; Fan J; Li H; Ding Z; Fu J; Wu Y; Zeng Y; Liu J
BMC Cancer; 2022 Sep; 22(1):999. PubMed ID: 36127654
[TBL] [Abstract][Full Text] [Related]
30. Development and validation of a robust epithelial-mesenchymal transition (EMT)-related prognostic signature for hepatocellular carcinoma.
Chen S; Zhao E
Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101587. PubMed ID: 33662631
[TBL] [Abstract][Full Text] [Related]
31. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
[TBL] [Abstract][Full Text] [Related]
32. A signature of 33 immune-related gene pairs predicts clinical outcome in hepatocellular carcinoma.
Sun XY; Yu SZ; Zhang HP; Li J; Guo WZ; Zhang SJ
Cancer Med; 2020 Apr; 9(8):2868-2878. PubMed ID: 32068352
[TBL] [Abstract][Full Text] [Related]
33. Identification of hepatocellular carcinoma prognostic markers based on 10-immune gene signature.
Zhao K; Xu L; Li F; Ao J; Jiang G; Shi R; Chen F; Luo Q
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32789471
[TBL] [Abstract][Full Text] [Related]
34. A pyroptosis-related gene signature predicts prognosis and immune microenvironment in hepatocellular carcinoma.
Jin Y; Pu X; Ping D; Huang C; Ding G; Cao L
World J Surg Oncol; 2022 Jun; 20(1):179. PubMed ID: 35659304
[TBL] [Abstract][Full Text] [Related]
35. Study on the gene signature related to immune microenvironment on viral and nonviral infections of hepatocellular carcinoma.
Qian H; Song S; Tian Y; Qi L; Gao H; Yuan L
Medicine (Baltimore); 2021 Apr; 100(15):e25374. PubMed ID: 33847635
[TBL] [Abstract][Full Text] [Related]
36. Integrative Analysis Reveals the Potential Role and Prognostic Value of GOLM1 in Hepatocellular Carcinoma.
Lin Y; He Z; Gao X; Lu L; Lu C; Huang J; Luo M; Ye J; Liang R
Oxid Med Cell Longev; 2022; 2022():8284500. PubMed ID: 36211823
[TBL] [Abstract][Full Text] [Related]
37. Identification of chromatin organization-related gene signature for hepatocellular carcinoma prognosis and predicting immunotherapy response.
Chen J; Chen X; Li T; Wang L; Lin G
Int Immunopharmacol; 2022 Aug; 109():108866. PubMed ID: 35691273
[TBL] [Abstract][Full Text] [Related]
38. A 4-gene prognostic signature predicting survival in hepatocellular carcinoma.
Chen PF; Li QH; Zeng LR; Yang XY; Peng PL; He JH; Fan B
J Cell Biochem; 2019 Jun; 120(6):9117-9124. PubMed ID: 30582205
[TBL] [Abstract][Full Text] [Related]
39. Development and Optimization of a Prognostic Model Associated with Stemness Genes in Hepatocellular Carcinoma.
Zhang K; Xie K; Huo X; Liu L; Liu J; Zhang C; Wang J
Biomed Res Int; 2022; 2022():9168441. PubMed ID: 36246969
[TBL] [Abstract][Full Text] [Related]
40. Relationships of Cuproptosis-Related Genes With Clinical Outcomes and the Tumour Immune Microenvironment in Hepatocellular Carcinoma.
Chen X; Hu G; Xiong L; Xu Q
Pathol Oncol Res; 2022; 28():1610558. PubMed ID: 36213162
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
